US tariff imposition to hit pharma section; auto sector prone to face minimal impression, ETCFO
India presently levies round 10 per cent import responsibility on American medication, whereas the US does not cost any import responsibility on Indian medication. Enhanced tariffs on pharma imports within the US can severely impression Indian drug producers as it might result in greater manufacturing prices, making shipments much less aggressive towards merchandise from different…